Rep. Shri Thanedar

Maddy summaryHR 6109 amends Medicare Advantage plan rules to address excessive initial denials of prior authorizations. It requires the Medicare program to terminate contracts with plans that reverse more than 25% of initially denied coverage requests through appeal or reconsideration during a plan year. The bill specifically targets plans where a high rate of reversed denials indicates improper initial denials, or where plans fail to properly reconsider denials compared to prior years. This directly affects Medicare Advantage plan providers, imposing new accountability for their prior authorization practices.

Maddy summaryThis bill amends Section 1983 of federal law (42 U.S.C. 1983) to explicitly allow lawsuits against federal officials who violate constitutional rights while acting under federal authority. It directly affects individuals whose constitutional rights were allegedly infringed by federal employees, such as law enforcement or agency staff. The key provision inserts "of the United States" before "of any State" in the statute, expanding the existing legal remedy for state officials to cover federal officials as well. This creates a clear, standalone legal path for citizens to seek redress for federal constitutional violations without relying on precedent.

Maddy summaryThis bill requires oil, gas, and geothermal companies to test nearby underground drinking water sources before, during, and after hydraulic fracturing ("fracking") operations. Companies must conduct testing at specified intervals (e.g., before starting, every 6 months during operations, annually for 5 years after) and submit results to the EPA within two weeks. The EPA will maintain a public database of all test results, making it searchable by ZIP code for community access. The requirement does not apply to sites with no accessible drinking water sources within one mile.

Maddy summaryThis bill limits how many Medicare Advantage (MA) plans a single organization can offer under Medicare contracts. It prohibits the Medicare program from contracting with an MA organization for more than three plans in a single year, and requires that if an organization offers multiple plans, each must be meaningfully different in premiums, benefits, or out-of-pocket costs. The rule applies to new or renewed contracts starting one year after the bill becomes law. It directly affects MA plan providers and Medicare's contracting process, aiming to reduce plan complexity for beneficiaries.

Maddy summaryThe CLEANER Act of 2025 requires the EPA to evaluate within one year whether drilling fluids, produced waters, and other wastes from oil, gas, and geothermal operations qualify as hazardous waste under federal law. If determined hazardous, the EPA must list these wastes and create tailored regulations for their handling, while also setting new safety standards for facilities managing non-hazardous waste from these sources. Key provisions include mandatory groundwater monitoring, location criteria for waste facilities, and financial assurance requirements to protect public health and the environment. This bill directly affects oil and gas producers, waste management facilities, and geothermal energy operations by imposing new regulatory obligations on their waste streams.

Maddy summaryThis bill requires Medicare Advantage (MA) plan advertisements to disclose specific data about prior authorization denials. Starting one year after enactment, ads must include the number of denied prior authorization requests, how many were later approved after reconsideration, and the average time between denial and approval. These disclosures must cover the most recent plan year before the ad is published, using both verbal and visual methods where possible. The policy directly affects MA plan marketers and beneficiaries who view these advertisements, aiming to provide clearer information about plan coverage experiences.

Maddy summaryThis bill requires oil and gas companies conducting hydraulic fracturing operations to disclose detailed chemical ingredients before starting and within 30 days after completing operations. Companies must provide full chemical names, CAS numbers, safety data sheets, and volumes to state or federal authorities, who then make this information publicly available online. The bill includes an exception allowing immediate disclosure of proprietary chemical formulas during medical emergencies, though companies can later request confidentiality agreements. It directly affects fracking operators in oil, gas, and geothermal production, amending the Safe Drinking Water Act to mandate transparency while maintaining trade secret protections outside emergency situations.

Maddy summaryHR 6108 requires the federal government to automatically exclude from all federal health care programs anyone convicted of specific fraud-related crimes after a one-year implementation period. It targets convictions for health care fraud, theft, or financial misconduct in health care delivery or government programs (including non-health care programs funded by government). The bill mandates this exclusion without requiring additional administrative action by the Secretary. This directly affects health care providers and organizations found guilty of such offenses, barring them from participating in programs like Medicare or Medicaid.

Maddy summaryThis bill (HR 6110) requires Medicare Advantage plans to automatically reconsider coverage denials without needing an enrollee to request it. It directly affects Medicare Advantage beneficiaries whose initial coverage requests are denied. The key change amends existing law to eliminate the requirement for patients to submit a separate request for reconsideration, instead mandating that plans proactively review these denials. This streamlines the process for enrollees facing coverage rejections under their Medicare Advantage plan.

Maddy summaryThe Biomanufacturing Excellence Act of 2025 establishes a National Biopharmaceutical Manufacturing Center of Excellence under the National Institute of Standards and Technology (NIST). It authorizes $120 million in funding for fiscal year 2026 to competitively award a grant to eligible entities - such as public-private partnerships, universities, or consortia - to create this center. The center will advance biopharmaceutical manufacturing technology, strengthen U.S. supply chains for medicines, and develop workforce training programs, with a focus on products critical to national security, health, and economic security. It requires annual progress reports to Congress and mandates the center to collaborate with manufacturers, research institutions, and educational partners to scale innovative production methods.